YKT61 Antibody

What is YKT61 and why is it important in plant biology research?

YKT61 is an atypical R-SNARE protein in Arabidopsis thaliana that plays a critical role in root apical meristem (RAM) development through brassinosteroid (BR) signaling pathways. This protein is essential for the dynamic targeting of BRASSINOSTEROID-INSENSITIVE1 (BRI1) to the plasma membrane, which is crucial for BR signaling. The significance of YKT61 is highlighted by its vital functions in multiple cellular processes, including vacuole biogenesis, Golgi morphology maintenance, and endocytosis . Functional loss of YKT61 has been shown to be lethal for both male and female gametophytes, underscoring its fundamental importance in plant development . Researchers developing antibodies against YKT61 can contribute significantly to understanding membrane trafficking mechanisms in plants and potentially in other organisms with homologous proteins.

What are the primary considerations when selecting YKT61 epitopes for antibody development?

When selecting epitopes for YKT61 antibody development, researchers should consider:

• Sequence uniqueness: Choose regions that are specific to YKT61 and not conserved among other SNARE proteins to avoid cross-reactivity.

• Surface accessibility: Target regions likely to be exposed on the protein surface rather than buried within the structure.

• Secondary structure stability: Avoid regions with highly flexible structures that might adopt multiple conformations.

• Post-translational modifications: Consider whether the target region undergoes phosphorylation or other modifications that might affect antibody recognition.

• Evolutionary conservation: If the antibody needs to recognize YKT61 across species, select epitopes in conserved regions.

This epitope selection process directly impacts the specificity and utility of the resulting antibodies, aligning with standard approaches in therapeutic antibody development that prioritize specificity to avoid off-target effects .

How do I establish a baseline validation protocol for newly developed YKT61 antibodies?

A comprehensive validation protocol for YKT61 antibodies should include:

• Western blot analysis: Confirm antibody recognition of recombinant YKT61 protein and native protein from plant extracts, with appropriate positive and negative controls.

• Immunoprecipitation: Verify the antibody's ability to pull down YKT61 from plant cell lysates.

• Immunofluorescence: Validate subcellular localization patterns, which should align with known YKT61 distribution in endomembrane compartments.

• Knockout/knockdown controls: Test antibody specificity using YKT61 mutants or knockdown lines like the ykt61-partially complemented (ykt61-pc) mentioned in the literature .

• Cross-reactivity assessment: Evaluate potential cross-reactivity with other SNARE proteins.

The validation standards should parallel those used in therapeutic antibody development frameworks, where rigorous quality control is essential for ensuring reproducible and reliable research outcomes .

How can co-immunoprecipitation with YKT61 antibodies be optimized to study interactions with BRI1 and other membrane proteins?

Optimizing co-immunoprecipitation (co-IP) for YKT61 and its interacting partners requires careful consideration of membrane protein extraction and interaction preservation:

• Membrane solubilization: Use mild detergents like digitonin (0.5-1%) or CHAPS (0.5-1%) that maintain protein-protein interactions while effectively solubilizing membrane proteins.

• Buffer composition optimization:

  • Ionic strength: Maintain 150-300 mM NaCl to reduce non-specific binding

  • pH stability: Use pH 7.2-7.4 to maintain native protein conformations

  • Divalent cations: Include 1-2 mM MgCl₂ to stabilize membrane protein complexes

• Cross-linking considerations: For transient interactions, implement reversible cross-linkers like DSP (dithiobis(succinimidyl propionate)) at 0.5-2 mM concentration for 30 minutes before cell lysis.

• Antibody orientation: Consider using oriented antibody coupling to beads using protein A/G with directional cross-linking to maximize antigen binding capacity.

• Washing stringency gradients: Implement sequential washing steps with decreasing detergent concentrations (0.1-0.05%) to remove non-specific binders while preserving specific interactions.

This method has successfully demonstrated that YKT61 physically interacts with BRI1, substantiating its role in BR-controlled RAM development . Careful application of these techniques can further elucidate the broader interactome of YKT61 within membrane trafficking pathways.

What are the critical parameters for quantitative analysis of YKT61 expression in different plant tissues and developmental stages?

Quantitative analysis of YKT61 expression requires careful calibration and normalization across different experimental conditions:

• Reference gene selection: For plant tissues, use at least three stable reference genes (e.g., ACT2, UBQ10, and PP2A) validated for expression stability across the tissues and developmental stages being studied.

• Sample normalization strategies:

  Normalization Method	Application Scenario	Advantages
  Geometric averaging of multiple reference genes	Cross-tissue comparison	Reduces bias from single reference gene variations
  Total protein normalization	When reference gene expression varies	Independent of transcriptional effects
  Absolute quantification using recombinant YKT61 standards	For precise copy number determination	Provides absolute rather than relative quantification

• Statistical validation requirements: Implement biological triplicates and technical duplicates at minimum, using ANOVA with post-hoc tests for multi-condition comparisons.

• Protein extraction efficiency controls: Include spike-in controls of recombinant YKT61 in different tissue extracts to account for matrix effects that might influence extraction efficiency, especially important when comparing expression between root apical meristem and other tissue types .

• Comparative analysis with transcript levels: Correlate protein levels with RT-qPCR data to identify potential post-transcriptional regulation mechanisms affecting YKT61 abundance.

These parameters ensure robust quantitative comparisons that can reveal tissue-specific and developmental regulation of YKT61, contributing to a comprehensive understanding of its roles in different plant contexts.

How should researchers interpret contradictory results between YKT61 antibody-based localization studies and fluorescent protein fusion approaches?

When facing discrepancies between antibody-based localization and fluorescent protein fusions of YKT61, consider these analytical approaches:

• Identify potential sources of discrepancy:

  • Antibody epitope accessibility may vary in different subcellular compartments

  • Fluorescent protein fusions might disrupt protein trafficking or interactions

  • Fixation protocols can alter native protein localization

  • Overexpression artifacts from fusion proteins vs. endogenous levels detected by antibodies

• Validation strategy matrix:

  Technique	Strengths	Limitations	Reconciliation Approach
  Antibody detection	Visualizes endogenous protein	Potential fixation artifacts	Use live-cell compatible immunolabeling
  N-terminal FP fusion	Maintains C-terminal functional domains	May affect membrane insertion	Create complementary C-terminal fusion
  C-terminal FP fusion	Preserves signal sequences	May disrupt protein interactions	Confirm functionality through rescue experiments
  Split-FP complementation	Verifies protein interactions in vivo	Requires protein partner co-expression	Use as orthogonal validation of antibody co-localization

• Reconciliation experiments:

  • Perform super-resolution microscopy with both methods

  • Use correlative light and electron microscopy (CLEM)

  • Implement proximity ligation assays to verify interactions detected by co-localization

  • Conduct organelle fractionation followed by immunoblotting to biochemically validate localization

• Functional correlation analysis: Compare phenotypic effects of YKT61 knockdown on cellular processes like vacuole biogenesis and endocytosis with localization patterns to determine which method better predicts functional outcomes.

What is the optimal strategy for developing antibodies against different domains of YKT61 for studying its functional interactions?

A strategic approach to developing domain-specific YKT61 antibodies requires thoughtful targeting of functional regions:

• Domain-specific targeting strategy:

  YKT61 Domain	Function	Antibody Application	Design Considerations
  N-terminal longin domain	Regulatory function	Study auto-inhibition mechanisms	Use peptide-based immunization with carrier protein conjugation
  SNARE motif	Membrane fusion	Detect active conformation	Target conserved residues within the motif for cross-species application
  C-terminal transmembrane domain	Membrane anchoring	Study localization determinants	Develop antibodies against junction regions adjacent to transmembrane domain

• Specialized immunization protocols:

  • For conformational epitopes: Use recombinant protein fragments expressed in eukaryotic systems

  • For linear epitopes: Employ synthetic peptides with strategic carrier protein conjugation

  • For rare conformations: Implement constrained peptides mimicking active/inactive states

• Screening methodology optimization:

  • Initial screening: ELISA against immunizing antigen

  • Secondary validation: Domain-specific binding confirmation through deletion mutant panel analysis

  • Functional screening: Evaluate antibodies for inhibition of YKT61-BRI1 interaction

• Paired antibody development: Generate complementary antibodies recognizing different epitopes for proximity-based assays (PLA) to study YKT61 interactions with BRI1 and other components of vesicular trafficking machinery.

This multi-domain antibody development approach provides researchers with specialized tools to dissect the distinct functional roles of YKT61 domains in membrane trafficking and plant development, generating more mechanistic insights than possible with a single antibody.

How can I optimize immunohistochemistry protocols for detecting YKT61 in plant root cross-sections?

Immunohistochemistry for detecting YKT61 in plant root tissues requires specialized protocols that preserve both tissue architecture and protein epitopes:

• Sample preparation optimization:

  • Fixation: Use 4% paraformaldehyde with 0.1-0.3% glutaraldehyde to maintain cellular ultrastructure while preserving antigenicity

  • Embedding options: Compare paraffin vs. cryosectioning vs. resin embedding for optimal epitope preservation

  • Section thickness: Maintain 5-8 μm sections for sufficient antibody penetration while preserving tissue context

• Epitope retrieval matrix:

  Method	Parameters	Application
  Heat-induced (citrate buffer)	pH 6.0, 95°C, 20 min	General protocol starting point
  Protease-induced	Proteinase K (10 μg/mL), 10 min	For heavily fixed samples
  Detergent permeabilization	0.1% Triton X-100, 15 min	For membranes with minimal fixation

• Signal amplification considerations:

  • Tyramide signal amplification: Increases sensitivity 10-50 fold for low-abundance YKT61

  • Quantum dot conjugated secondary antibodies: Provide photostability for extended imaging

  • Multiplexing strategies: Use spectral unmixing for co-localization with BRI1 and other markers

• Background reduction strategies:

  • Plant-specific autofluorescence blocking: Use 0.1% Sudan Black B in 70% ethanol

  • Endogenous peroxidase quenching: 3% H₂O₂ treatment for 10 minutes when using HRP-based detection

  • Pre-adsorption controls: Incubate antibody with recombinant YKT61 to confirm staining specificity

• Validation through comparative analysis with YKT61 knockdown mutants (ykt61-pc) to confirm staining pattern specificity.

These optimized protocols enable precise localization of YKT61 within the root apical meristem, facilitating studies of its role in cell division and BR signaling within specific cell types and developmental zones.

What controls and validation steps are necessary for phospho-specific YKT61 antibodies to study its potential regulation by phosphorylation?

Developing and validating phospho-specific antibodies for YKT61 requires rigorous controls:

• Essential validation controls:

  • Dephosphorylation treatment: Compare antibody reactivity before and after sample treatment with lambda phosphatase

  • Phosphomimetic mutants: Test recognition of phosphomimetic (S→D or T→E) and phospho-dead (S→A or T→A) YKT61 variants

  • Peptide competition: Perform blocking experiments with phosphorylated vs. non-phosphorylated peptides

• Validation methodology matrix:

  Technique	Primary Purpose	Critical Controls
  Western blot	Verify size and specificity	Include λ-phosphatase treated samples alongside untreated
  Immunoprecipitation	Enrich phospho-forms	Validate with mass spectrometry confirmation of phosphorylation sites
  Immunofluorescence	Localize phosphorylated YKT61	Compare with total YKT61 distribution using dual labeling
  Phosphorylation-dependent PLA	Detect proximity to kinases	Include phosphatase inhibitor gradients to establish sensitivity

• Kinase prediction and validation:

  • In silico analysis: Identify candidate kinases for YKT61 phosphorylation

  • In vitro kinase assays: Confirm direct phosphorylation by candidate kinases

  • Inhibitor studies: Use specific kinase inhibitors to validate the signaling pathway in vivo

• Physiological correlation analysis:

  • Monitor phosphorylation status during BR signaling activation

  • Correlate phosphorylation with YKT61-BRI1 interaction dynamics

  • Analyze phosphorylation changes during cell division in the root apical meristem

These validation steps ensure that phospho-specific antibodies accurately detect post-translational modifications of YKT61, enabling researchers to uncover regulatory mechanisms controlling its function in membrane trafficking and BR signaling.

How can ChIP-seq approaches be optimized using YKT61 antibodies to study its potential nuclear functions?

While YKT61 is primarily known as a membrane trafficking protein, investigating potential moonlighting functions in the nucleus requires specialized ChIP-seq optimization:

• Nuclear fraction enrichment protocol:

  • Implement a sequential extraction method to separate membrane-bound and nuclear YKT61 pools

  • Verify nuclear enrichment through western blot comparison with known compartment markers

  • Use mild crosslinking conditions (0.1% formaldehyde, 10 minutes) to preserve transient nuclear interactions

• ChIP optimization parameters:

  Parameter	Recommendation	Rationale
  Sonication conditions	10-15 cycles (30s on/30s off) at 30% amplitude	Balance between chromatin fragmentation (200-500bp) and epitope preservation
  Antibody concentration	3-5 μg per 25 μg chromatin	Higher ratio than standard ChIP due to potentially lower nuclear abundance
  Pre-clearing strategy	Extended pre-clearing (2h) with protein A/G beads	Reduce background from membrane components
  Washing stringency	Implement gradient washing with increasing salt concentration	Remove membrane-derived artifacts while preserving specific interactions

• Bioinformatic analysis considerations:

  • Compare peak distributions with known transcription factors involved in BR signaling

  • Analyze motif enrichment for DNA binding preferences

  • Correlate binding patterns with gene expression changes in YKT61 knockdown plants

• Validation experiments:

  • Perform ChIP-qPCR on selected targets

  • Use DNA-protein interaction assays (EMSA, DNA pull-down) to confirm direct binding

  • Implement proximity ligation assays to validate nuclear interactions in situ

This approach can reveal whether YKT61, beyond its established role in membrane trafficking and brassinosteroid signaling , might function in retro-signaling pathways from the endomembrane system to the nucleus, potentially influencing transcriptional responses.

What methodological approaches can distinguish between direct and indirect effects of YKT61 on BRI1 trafficking?

Distinguishing direct from indirect effects of YKT61 on BRI1 trafficking requires multi-faceted experimental approaches:

• Temporal resolution strategies:

  • Inducible YKT61 depletion: Use dexamethasone-inducible RNAi or auxin-inducible degradation systems to monitor immediate vs. delayed effects on BRI1 localization

  • Real-time imaging: Implement photoconvertible BRI1 fusions to track newly synthesized vs. recycling pools

• Interaction proximity analysis:

  Technique	Application	Resolution Power
  Bimolecular Fluorescence Complementation (BiFC)	Visualize direct YKT61-BRI1 interaction	Confirms proximity (<10nm) but not functional consequence
  Förster Resonance Energy Transfer (FRET)	Measure interaction dynamics	Provides real-time interaction data with nanometer resolution
  Co-immunoprecipitation with truncation mutants	Map interaction domains	Identifies specific regions required for physical interaction
  Proximity-dependent biotin labeling (BioID)	Identify neighborhood proteins	Distinguishes direct from nearby interactors in native context

• Trafficking pathway dissection:

  • Compartment-specific YKT61 targeting: Direct YKT61 to specific endomembrane compartments to determine where interaction with BRI1 is functional

  • Vesicular trafficking inhibitors: Use brefeldin A, wortmannin, and other inhibitors to block specific trafficking routes

  • Dominant-negative Rab GTPase expression: Selectively impair distinct trafficking steps to pinpoint YKT61 function

• Reconstitution experiments:

  • In vitro vesicle fusion assays with purified components

  • Semi-permeabilized cell systems with controlled addition of YKT61 variants

  • Heterologous expression systems to test sufficiency of YKT61 for BRI1 trafficking

These approaches collectively address the reported physical interaction between YKT61 and BRI1 , clarifying whether YKT61 directly mediates BRI1 recycling or influences it indirectly through effects on endomembrane organization and function.

How can super-resolution microscopy be optimized for studying YKT61 distribution in relation to membrane trafficking events?

Optimizing super-resolution microscopy for YKT61 localization requires specialized sample preparation and imaging parameters:

• Super-resolution technique selection matrix:

  Technique	Resolution Limit	Best Application	YKT61-Specific Considerations
  Structured Illumination Microscopy (SIM)	~100 nm	Multi-color dynamic imaging	Ideal for co-localization with BRI1 in living cells
  Stimulated Emission Depletion (STED)	~30-70 nm	High-resolution membrane imaging	Best for detailing YKT61 membrane distribution
  Single-Molecule Localization Microscopy (SMLM)	~20 nm	Precise protein clustering analysis	Requires photo-switchable fluorophores conjugated to YKT61 antibodies
  Expansion Microscopy	~70 nm (combined with SIM)	Isotropic 3D resolution	Useful for preserving spatial relationships in complex tissues

• Sample preparation optimization:

  • Fixation parameters: Use 4% PFA with minimal glutaraldehyde (0.05-0.1%) to preserve nanoscale structure

  • Fluorophore selection: Implement bright, photostable dyes (Alexa 647, Janelia Fluor 646) for optimal signal-to-noise ratio

  • Mounting media: Use oxygen scavenging systems with reducing agents for SMLM techniques

• Quantitative analysis frameworks:

  • Colocalization analysis: Use object-based approaches rather than pixel-based methods

  • Cluster analysis: Implement Ripley's K-function or DBSCAN to quantify YKT61 nanoclustering

  • Tracking analysis: For live-cell imaging, use single-particle tracking to monitor YKT61-positive vesicle dynamics

• Correlative approaches:

  • CLEM (Correlative Light and Electron Microscopy): Combine super-resolution with EM to visualize YKT61 in context of membrane ultrastructure

  • Functional correlation: Link dynamic YKT61 redistribution to BRI1 recycling and BR signaling outputs

These optimized super-resolution approaches can reveal the precise spatial organization of YKT61 relative to endomembrane compartments, providing insights into its role in vesicle fusion, vacuole biogenesis, and Golgi morphology maintenance as reported in the literature .

What are the recommended approaches for generating monoclonal antibodies against YKT61 with minimal cross-reactivity to other SNARE proteins?

Generating highly specific monoclonal antibodies against YKT61 requires strategic immunization and screening approaches:

• Immunogen design considerations:

  • Sequence analysis: Perform detailed alignment of YKT61 with other R-SNARE proteins to identify unique regions

  • Structural prediction: Use in silico methods to identify surface-exposed regions unique to YKT61

  • Antigenicity prediction: Implement algorithms that predict B-cell epitopes with high antigenicity scores

• Hybridoma development strategy:

  Stage	Critical Parameters	Specific Recommendations
  Immunization	Adjuvant selection	Use RIBI or alum for balanced Th1/Th2 response
  Fusion	Fusion partner	SP2/0 cells for higher stability of resulting hybridomas
  Initial screening	High-throughput approach	Implement automated ELISA against YKT61 and related SNARE proteins
  Counter-screening	Negative selection	Eliminate clones that cross-react with other plant SNAREs
  Subcloning	Stability assessment	Three rounds of limiting dilution with consistent specificity testing

• Advanced specificity validation:

  • Tissue cross-reactivity studies using plant tissues from wild-type and YKT61 knockdown plants

  • Epitope mapping to confirm targeting of unique YKT61 regions

  • Competition assays with recombinant YKT61 vs. other SNARE proteins

• Production and purification optimization:

  • Adapt hybridomas to serum-free culture for consistent antibody production

  • Implement protein A or G affinity purification followed by size exclusion chromatography

  • Validate batch-to-batch consistency through specificity assays

This comprehensive approach to monoclonal antibody development follows established principles from therapeutic antibody development , ensuring high specificity for YKT61 that will enable reliable detection in complex plant samples.

How should researchers design experiments to validate YKT61 antibodies for different applications (Western blot, IP, IHC, ELISA)?

A systematic validation approach for different applications requires application-specific controls and optimization:

• Application-specific validation matrix:

  Application	Primary Validation	Secondary Validation	Critical Controls
  Western blot	Band specificity at predicted MW	Detection limit determination	YKT61 knockdown samples , recombinant protein positive control
  Immunoprecipitation	Pull-down efficiency	Interaction partner co-IP	IgG control, pre-clearing optimization
  Immunohistochemistry	Localization pattern specificity	Signal-to-noise optimization	Peptide competition, secondary-only controls
  ELISA	Standard curve linearity	Cross-reactivity assessment	Recombinant protein standards, matrix effect evaluation

• Quantitative performance benchmarks:

  • Western blot: Sensitivity to detect <10 ng of YKT61, linearity across 2-log concentration range

  • IP: >70% pull-down efficiency from total lysate, <10% non-specific binding

  • IHC: >5:1 signal-to-background ratio, pattern consistency across fixation methods

  • ELISA: Detection range of 0.1-100 ng/mL, CV <15% across replicates

• Cross-application consistency assessment:

  • Compare subcellular localization between fractionation/Western blot and immunofluorescence

  • Verify that proteins identified in IP-MS match localization patterns from IHC

  • Correlate ELISA quantification with Western blot band intensities

• Specific considerations for plant samples:

  • Implement methods to overcome plant-specific challenges (phenolics, polysaccharides)

  • Include tissue-specific matrix controls to account for differential extraction efficiency

  • Validate across multiple plant developmental stages and tissues

This comprehensive validation ensures that YKT61 antibodies perform reliably across multiple applications, generating consistent results that accurately reflect YKT61 biology in processes like brassinosteroid signaling and root apical meristem development .

What are the critical quality control parameters for assessing lot-to-lot consistency of YKT61 antibodies in long-term research projects?

Ensuring lot-to-lot consistency for YKT61 antibodies over extended research projects requires systematic quality control:

• Critical quality attributes (CQAs) to monitor:

  Parameter	Acceptance Criteria	Testing Method
  Antibody concentration	Within ±10% of specification	BCA/Bradford assay, A280 measurement
  Epitope recognition	Consistent EC50 in direct ELISA	Dose-response binding assay to target epitope
  Specificity profile	No new cross-reactivity	Western blot against plant lysate panel
  Functional activity	IP efficiency within 20% of reference lot	Quantitative IP recovery analysis
  Aggregation level	<5% high molecular weight species	Size exclusion chromatography

• Reference standard implementation:

  • Create master reference standard from large, well-characterized lot

  • Aliquot and store at -80°C for long-term stability

  • Use side-by-side comparisons for each new lot qualification

• Stability monitoring program:

  • Real-time stability: Test activity at 0, 3, 6, 12, 24 months under recommended storage

  • Accelerated stability: Higher temperature conditions to predict long-term performance

  • Freeze-thaw stability: Validate performance after multiple freeze-thaw cycles

• Application-specific performance tracking:

  • Western blot: Maintain digital library of standard blots for visual comparison

  • Immunofluorescence: Document standardized images of YKT61 localization pattern

  • ELISA: Track standard curve parameters (slope, intercept, R²) across lots

• Certificate of Analysis documentation for each lot, including:

  • Production date and expiration assignment

  • All QC test results with acceptance criteria

  • Reference standard comparison data

  • Recommended storage and handling conditions

This systematic approach to antibody quality control follows principles established in therapeutic antibody development , ensuring consistent performance of YKT61 antibodies throughout long-term research projects investigating membrane trafficking and brassinosteroid signaling pathways .

How can quantitative proteomics be combined with YKT61 antibodies to identify novel interaction partners in different plant cell types?

Integrating YKT61 antibodies with quantitative proteomics requires specialized approaches for membrane protein complexes:

• Complementary immunoprecipitation strategies:

  Method	Specific Application	Technical Considerations
  Standard IP-MS	Stable interactions	Use mild detergents (0.5% CHAPS) for membrane protein extraction
  Cross-linking IP-MS	Transient interactions	Implement DSP or formaldehyde crosslinking before cell lysis
  Proximity-dependent labeling	Spatial proteomics	Express YKT61-BioID fusion to identify neighborhood proteins
  Co-IP from fractionated samples	Compartment-specific interactome	Perform organelle isolation before immunoprecipitation

• Quantitative MS approaches for differential interaction analysis:

  • SILAC: Metabolic labeling to compare wild-type vs. BR-treated samples

  • TMT/iTRAQ: Multiplexed comparison across developmental stages or treatments

  • Label-free quantification: For direct comparison between tissue types

• Data filtering and validation pipeline:

  • Implement SAINT or similar statistical tools for identifying high-confidence interactors

  • Filter against CRAPome database to remove common contaminants

  • Apply transmembrane domain and secretory pathway signal predictions to prioritize likely interactors

• Biological context integration:

  • Network analysis to place YKT61 interactors in BR signaling and membrane trafficking pathways

  • GO term enrichment to identify overrepresented cellular processes

  • Correlation with phenotypic data from YKT61 knockdown plants

• Orthogonal validation requirements:

  • Co-localization studies for selected high-confidence interactors

  • Binary interaction confirmation through Y2H or split-fluorescent protein complementation

  • Functional validation through mutant analysis of identified partners

This integrated approach can expand our understanding of YKT61's role beyond its known interaction with BRI1 , potentially revealing novel connections between membrane trafficking, brassinosteroid signaling, and other developmental pathways in plants.

What comparative analysis approaches can differentiate the functions of YKT61 from other R-SNARE proteins using specific antibodies?

Differential analysis of R-SNARE proteins requires strategic use of specific antibodies and comparative experimental designs:

• Paralog-specific antibody panel development:

  • Generate antibodies against unique regions of YKT61 and related R-SNAREs

  • Validate specificity through Western blot against recombinant proteins

  • Ensure comparable affinities to enable quantitative comparisons

• Comparative localization matrix:

  Analysis Level	Technique	Analytical Approach
  Subcellular distribution	Multi-color immunofluorescence	Colocalization coefficients with organelle markers
  Tissue expression patterns	Immunohistochemistry	Digital quantification of expression across tissues
  Developmental regulation	Developmental Western blot series	Temporal expression profiling during plant growth
  Stimulus-dependent redistribution	Time-course analysis after BR treatment	Quantitative translocation analysis

• Functional redundancy assessment:

  • Comparative IP-MS to identify unique vs. shared interaction partners

  • Sequential immunodepletion to determine unique contribution of each R-SNARE

  • Antibody inhibition studies in semi-permeabilized cell systems

• Comparative phenotypic correlation:

  • Correlate localization patterns with distinct phenotypes of different R-SNARE mutants

  • Analyze trafficking defects specific to YKT61 knockdown vs. other R-SNARE mutations

  • Assess BR response specificity through BRI1 localization in different R-SNARE mutants

• Evolutionary context integration:

  • Compare functional conservation of YKT61 orthologs across plant species

  • Analyze differences in interaction networks between diversified R-SNAREs

This comparative approach can distinguish the specific roles of YKT61 in root apical meristem development and BRI1 trafficking from potentially overlapping functions of other R-SNARE family members in plants.

How can researchers implement high-throughput screening to identify small molecules that modulate YKT61 function using antibody-based assays?

Developing antibody-based high-throughput screens for YKT61 modulators requires specialized assay designs:

• Primary screening assay formats:

  Assay Type	Target Measurement	Technical Implementation
  ELISA-based binding disruption	YKT61-BRI1 interaction	Capture one protein, detect other with specific antibody, compounds compete for interaction
  Cellular redistribution	YKT61 localization	High-content imaging with YKT61 antibodies to quantify subcellular distribution
  BRET/FRET biosensors	YKT61 conformational changes	Engineer sensors with antibody-derived binding domains
  AlphaScreen	Protein-protein interactions	Bead-based proximity assay using anti-YKT61 and anti-BRI1 antibodies

• Assay development parameters:

  • Miniaturization to 384- or 1536-well format

  • Optimization for Z' factor >0.5 for robust screening

  • DMSO tolerance assessment (typically 0.1-1%)

  • Positive controls: Competing peptides derived from interaction interfaces

• Secondary assay cascade:

  • Dose-response confirmation of primary hits

  • Orthogonal assays to confirm mechanism (e.g., microscopy, pull-down)

  • Selectivity panels against other R-SNAREs

  • Cellular phenotypic assays (root growth, BR response)

• Validation in plant systems:

  • Root growth assays with hit compounds

  • BR response markers in the presence of hits

  • Direct target engagement validation through cellular thermal shift assay (CETSA)

• Structure-activity relationship development:

  • Iterative chemical optimization guided by antibody-based assays

  • Structure-based design using YKT61 structural information

  • Computational docking to predict binding modes

This screening approach can identify chemical probes that modulate YKT61's role in BR-controlled RAM development , providing valuable tools for studying the temporal aspects of YKT61 function and potentially leading to new insights into membrane trafficking regulation in plants.